69 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Rank Status Study
21 Recruiting Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:
22 Recruiting A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
23 Recruiting Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs
Condition: Axial Spondyloarthritis
Interventions: Drug: Ibuprofen;   Drug: Placebo
24 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Biological: Human umbilical cord-derived MSCs
25 Recruiting Extension in AS: Sustainability of Benefits, Safety and Tolerability
Condition: Spondylitis, Ankylosing
Intervention: Biological: Secukinumab
26 Recruiting Registry of Korean Patients With Rheumatic Disease Using Biologics
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
27 Recruiting Delaying Ossification and Improving Inflammation of Celebrex Plus/or Enbrel Treatment on Active Ankylosing Spondylitis
Conditions: Inflammation;   Ankylosing Spondylitis
Interventions: Drug: celebrex;   Drug: Enbrel;   Drug: Enbrel plus Celebrex
28 Recruiting Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Hypertension
Interventions: Drug: Etanercept;   Drug: Adalimumab;   Drug: Certolizumab;   Drug: Infliximab
29 Not yet recruiting Patients Response to Early Switch To Oral:Osteomyelitis Study
Condition: Osteomyelitis
Interventions: Drug: oral antibiotics;   Procedure: intravenous antibiotics
30 Unknown  Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Condition: Moderate to Severe Active Axial Spondyloarthritis
Interventions: Drug: Etanercept 25mg;   Drug: Sulfasalazine
31 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
32 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
33 Unknown  Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis
Condition: Spondyloarthritis
Interventions: Drug: Adalimumab;   Drug: Placebo
34 Unknown  Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
Condition: Spondyloarthritis
Intervention: Drug: Adalimumab, Etanercept, or infliximab
35 Not yet recruiting PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Conditions: Cardiac Disease;   Dementia;   Inflammatory Disease;   Fever of Unknown Origin;   Vasculitis;   Osteomyelitis;   FDG Avid Cancers
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
36 Not yet recruiting Defining Remission With Etanercept in AS in Real Life Clinical Practice
Condition: Ankylosing Spondylitis
Intervention: Drug: etanercept
37 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
38 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
39 Not yet recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: Secukinumab;   Biological: Placebo
40 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years